Tibbiyah gets CMA approval for 51% stake in UAE health operator

Tibbiyah, a healthcare group listed on the Saudi Exchange (Tadawul), received Capital Market Authority (CMA) approval on 30 June 2022 to acquire a 51% stake in an unnamed UAE-based health company, Arab News reported. The deal gives Tibbiyah operational control and triggers re-licensing obligations with the relevant UAE health regulator.

What a majority stake requires under UAE health regulations

A change of control above 50% in a UAE-licensed health facility requires prior approval from the relevant emirate health authority. The required process differs by emirate:

• Ministry of Health and Prevention (MOHAP): Northern Emirates facilities must file a formal ownership-change application before the transaction closes.
• Dubai Health Authority (DHA): Dubai-licensed facilities require a license amendment before any change-of-control transaction closes.
• Abu Dhabi Department of Health (DOH): Abu Dhabi and Al Ain facilities face parallel ownership-transfer provisions.

The acquiring entity must confirm that existing clinical governance structures, Emiratisation staffing ratios, and quality accreditation conditions remain intact after the transfer. Failure to notify the relevant authority risks a formal license review, with suspension possible until the ownership structure is regularised.

Why Saudi operators are buying UAE healthcare assets

Saudi healthcare groups have increased their UAE exposure since at least 2020. Two structural factors make UAE private healthcare assets attractive to Gulf buyers. Abu Dhabi made employer-funded health insurance mandatory for all residents in 2006. Dubai completed its own phased insurance mandate by 2016. Those two policies created a stable, large-volume payer environment that supports consistent reimbursement, a contrast to the more variable Saudi private-pay market.

For Tibbiyah, a 51% position enables full financial consolidation on group accounts and direct management authority over the UAE entity. A sub-50% stake generates dividend income but not operational control, a distinction that matters for a listed company measuring return on capital employed across its portfolio.

Implications for UAE healthcare operators

UAE clinic chains and diagnostic groups without institutional backing may face continued acquisition approaches from Gulf-listed buyers. The CMA approval establishes a precedent that lowers the compliance burden for subsequent Saudi-to-UAE healthcare acquisitions structured the same way. Operators expecting acquisition interest should have their MOHAP, DHA, or DOH licensing files current, as a buyer's due diligence will examine active licenses, renewal dates, and any outstanding enforcement actions before deal close.

Tibbiyah did not disclose the financial value of the deal. Arab News did not identify the UAE target company by name. Regulatory filings with MOHAP, DHA, or DOH, depending on which emirate the target operates in, will confirm facility type, licensed capacity, and any conditions attached to the ownership transfer.